Approvals/TGA/DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle

Approved

STANDARD

DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle

ViiV Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 830213b3a2df0f94
Product Name: DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle
Artg Id: 309378
Artg Name: DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle
Sponsor: ViiV Healthcare Pty Ltd
Company Detail Path: /organization/viiv-healthcare-pty-ltd
Artg Date: 2019-09-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/266d5c86868b70254aa483b349f82815.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b9c0ff374b8f5f7aec92ef3ad6eee4ad.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

830213b3a2df0f94

Type

Standard